which had a circulating clone of cells in peripheral blood. In 7 patients the gene rearrangement in lymphoma tissue and peripheral blood mononuclear cells was identical. However, in 2 patients both heavy chain and light chain gene rearrangements were different in tissue and peripheral blood. The incidence of peripheral blood involvement was commonest in advanced CSIII & IV disease (54%) compared to CSI & II disease (18%) (P<0.05), and in low grade (45%) compared to intermediate and high grade lymphoma (31%) (difference not statistically significant). Only 4 patients had definite lymphoma cells seen on peripheral blood smear. The presence of circulating lymphoma cells correlated with conventional assessment of bone marrow involvement although circulating clones were detected in 30% (12/40) of patients with apparently normal bone marrow.
Lymphoma cells have been detected in peripheral blood by routine morphological examination of the blood smear (Come et al., 1980; Dick et al., 1974; Foucar et al., 1982; Garrett et al., 1979; McKenna et al., 1975) . Their presence in B-cell lymphoma has also been implied with k and . light chain staining and the demonstration of abnormal k/. ratio (Sobol et al., 1985; Johnson et al., 1985) , clonal excess (Ligler et al., 1980; Weinberg et al., 1984) or by cytofluorimetric studies (Smith et al., 1984) . With the advent of clonal analysis by immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangement studies of B-and T-ccll lymphomas (Arnold et al., 1983; Cleary et al., 1984; Bertness et al., 1985; O'Connor et al., 1985) , it has become possible to detect clonal rearrangement with up to I % sensitivity (Arnold et al. 1983) . This allows for the detection of clones of cells in peripheral blood and has already been successfully applied to patients with low grade B-cell lymphoma who have a high frequency of bone marrow and peripheral blood involvement (Hu et al., 1985) . We (Southern, 1975) Figure 1 ). Comparison of DNA hybridisation and conventional bone marrow assessment (Table V) shows a false negative rate for histology of 20% (2/10).
Discussion
As shown previously (Hu et al., 1985; Berliner et al., 1986) , we were able to demonstrate the presence of circulating clones of mononuclear cells in patients with non-Hodgkin's lymphoma as specific immunoglobulin or T-cell receptor gene rearrangements. Seven patients had identical gene rearrangement in peripheral blood and lymphoma tissue, suggesting that circulating clones of cells represent lymphoma cells. In 2 patients, both with recurrent disease, the pattern of heavy and light chain rearrangement differed between peripheral blood and lymphoma tissue and this could be ascribed to biclonality . Preservation of specific translocation detected by bcl-2 probe (pFl-2; Cleary et al., 1985) and identical VDJ joining sequences in cases described by Sklar et al. (1984) suggest that the apparent biclonality may also be due to somatic mutation (Cleary, personal communication) . In our cases this would have to be explained by two mutations.
Permanent cell lines of B-cell lineage can undergo further rearrangement by exchange with an upstream V segment (Reth et al., 1986; Kleinfield et al., 1986 Hu et al. (1985) reported identical Ig gene rearrangement in lymphoma tissue and circulating cells in 7 patients with follicular B-cell lymphoma. Identical light chains on circulating mononuclear cells and lymphoma tissue also suggest that the circulating clonal population represents lymphoma cells (Smith ct al., 1984) .
We detected circulating clones of cells in 19/50 (38%) patients with active lymphoma and the incidence of blood involvement was related to the extent of disease and possibly to histological grade (Table II) .
Lymphoma cells have been detected on peripheral blood smear in 8-20% of patients with NHL (Come et al., 1980; Dick et al., 1974; Foucar et al., 1982; McKenna et al., 1975; Morra et al., 1985) . With (Garrett et al., 1979; Johnson et al., 1985: igler et al.. 1980; Lindemalm et al., 1985; Sobol et al., 1985) . With cytofluorimetric analysis of k and A stained mononuclear cell populations the peripheral blood involvement has been reported in up to 78% of the patients studied (Smith et al., 1984) . Although, to some extent, these results reflect increased sensitivity of the more sophisticated techniques (Smith et al., 1984; Berliner et al., 1986) (Jaffe, 1983) , where tumour cells may retain some of the recirculation properties of normal lymphocytes (de Sousa, 1981 Smith et al. (1984) , using cytofluorimetry, detected circulating clones of cells in 80% of patients with normal bone marrow.
The possibility of peripheral lymphoma cells originating in lymphoma tissue cannot be excluded particularly if bone marrow is considered a transient stop in the recirculation of lymphocytes or if we adhere to the traditional view of spread from primary to metastatic sites via the blood stream. To answer the question of tumour cell origin it will be necessary to perform longitudinal studies, particularly in patients receiving only local therapy.
Clinical relevance and conclusion It remains to be shown if the detection of lymphoma cells in peripheral blood with such high sensitivity is of prognostic or therapeutic importance. Our findings support the view of low grade lymphoma as a systemic disease (Jaffe, 1983) . The detection of lymphoma cells in blood is unlikely to alter current treatment strategies except in early disease where local radiotherapy is the treatment of choice (Paryani et al., 1983; Sutcliffe et al., 1985) . Our findings of 25% of peripheral blood involvement in CSI and II NHL may indicate the source of failure in a proportion of these patients. If peripheral blood lymphoma cells represent bone marrow disease we may also speculate that in low grade lymphoma their detection will be of no prognostic significance (Bartl et al., 1982; Lindemalm et al., 1985; Bennett et al., 1986) .
Similar considerations apply to intermediate and high grade lymphomas although bone marrow involvement in these tumours is considered a poor prognostic factor (Fisher et al., 1981; Gams et al., 1985; Steward et al., 1984; Bennett et al., 1986) . With the increasingly successful use of chemotherapy in early-stage disease (Miller et al., 1983; Cabanillas, 1983) there is less need for exact delineation of tumour sites. However, if we consider local radiotherapy a less toxic treatment, the detection of circulating lymphoma cells may help in choosing the appropriate therapy, with systemic treatment reserved for truly systemic disease. In addition a sensitive method of detection of minimal disease in peripheral blood and bone marrow may have an important role in bone marrow transplantation, particularly if autologous marrow is used.
The search for circulating lymphoma cells by DNA hybridisation cannot at present be considered part of the routinie assessment of lymphoma patients. The exact role of this investigation remains to be defined and so far it is too unwieldy for regular clinical application. However, the prospect of observing tumour cells with such precision and 
